Tensegrity model hypothesis: May this paradigm be useful to explain hepatic and pancreatic carcinogenesis in patients with persistent hepatitis B or hepatitis C virus infection?

Journal of the Pancreas

Volumn 15, Issue 2, 2014, Pages 151-164

  Fiorino, Sirio ^a   Bacchi Reggiani, Letizia ^b   Pontoriero, Laura ^d   Gallo, Claudio ^e   Chili, Elisabetta ^f   Masetti, Michele ^g   Zanini, Nicola ^g   Grondona, Ana ^g   Silvestri, Tania ^g   Deleonardi, Gaia ^g   Fornelli, Adele ^g   Bondi, Arrigo ^g   de Biase, Dario ^h   Baccarini, Paola ^h   Tallini, Giovanni ^h   Tropeano, Antonio ⁱ   Quartuccio, Valeria ^j   Cuppini, Andrea ^a   Castellani, Gastone ^c   Jovine, Elio ^g  

^a Department of Radiology   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Elderly Care Unit   (Italy)

^e Physician Specialist of Infectious Diseases   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g MAGGIORE HOSPITAL   (Italy)

^h BELLARIA HOSPITAL   (Italy)

ⁱ Physician Specialist of Dentistry   (Italy)

^j UNIVERSITY OF CALABRIA   (Italy)

more..

Author keywords

Carcinoma; Cellular; Hepacivirus; Hepatitis B virus; Hepatocellular; Mechanotransduction; Pancreatic carcinoma

Indexed keywords

COLLAGEN TYPE 1; FOCAL ADHESION KINASE; NERVE CELL ADHESION MOLECULE; P CADHERIN; TRANSCRIPTION FACTOR RUNX2; UVOMORULIN;

APOPTOSIS; CANCER GROWTH; CONFERENCE PAPER; CYTOSKELETON; EXTRACELLULAR MATRIX; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CANCER; MODEL; PANCREAS CANCER; PROTEIN EXPRESSION; SCIENTIFIC LITERATURE; SIGNAL TRANSDUCTION;

EID: 84897864960     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: 10.6092/1590-8577%2F2099     Document Type: Conference Paper

References (107)

1. El-Serag. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142 (6): 1264-73. e1. doi: 10.1053/j.gastro.2011.12.061. [PMID: 22537432]
2. Bialek SR, Terrault NA. The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 2006; 10: 697- 715. [PMID: 17164113]
3. Dandri M, Locarnini S. New insight in the pathobiology of hepatitis B virus infection. Gut 2012; 2012;61 Suppl 1:i6-17. doi: 10.1136/gutjnl-2012-302056. [PMID: 22504921]
4. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001; 34: 730-9. [PMID: 11434620]
5. Fiorino S, Lorenzini S, Masetti M, Deleonardi G, Grondona AG, Silvestri T et al. Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma. Med Hypotheses. 2012;79(5):678-97. [PMID: 22959312]
6. Hassan MM, Li D, El-Deeb AS, Wolff RA, Bondy ML, Davila M et al. Association between hepatitis B virus and pancreatic cancer. J Clin Oncol 2008; 26:4557-62. [PMID: 18824707]
7. Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, et al. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study Liver Int, 2010; 30 (3): 423-429. [PMID 19840258]
8. Wang DS, Chen DL, Ren C, Wang ZQ, Qiu MZ, Luo HY, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer. 2012;131(2):461-8. [PMID: 21858814]
9. Ben Q, Li Z, Liu C, Cai Q, Yuan Y, Wang K, et al. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a casecontrol study from China. Pancreas. 2012; 41(3):435-40. [PMID: 22422136]
10. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology 2009;49:116-23. [PMID: 19085911]
11. Wang Y, Yang S, Song F, Cao S, Yin X, Xie J et al. Hepatitis B virus status and the risk of pancreatic cancer: a meta-analysis. Eur J Cancer Prev. 2013;22(4):328-34. doi: 10.1097/ CEJ.0b013e32835b6a21. [PMID: 23165286]
12. Luo G, Hao NB, Hu CJ, Yong X, Lu MH, Cheng BJ et al. HBV infection increases the risk of pancreatic cancer: a meta-analysis. Cancer Causes Control. 2013; 24 (3): 529-37. [PMID: 23306552]
13. Fiorino S, Chili E, Bacchi-Reggiani L, Masetti M, Deleonardi G, Grondona AG et al. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: A systematic review and meta-analysis. Pancreatology 2013; 147-60. [PMID 23561973]
14. Jin Y, Gao H, Chen H, Wang J, Chen M, Li G et al. Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues. Cancer Lett. 2013. doi: 10.1016/j.canlet.2013.03.001. [PMID: 23499889]
15. Jackson L, Evers BM. Chronic inflammation and pathogenesis of GI and pancreatic cancers. Cancer Treat Res 2006;130:39-65. [PMID: 16610702]
16. Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006;56(2):69-83. [PMID: 16514135]
17. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007;121(11):2373-80. [PMID: 17893866]
18. Kuo JC. Mechanotransduction at focal adhesions: integrating cytoskeletal mechanics in migrating cells. Cell Mol Med. 2013. doi: 10.1111/jcmm.12054. [PMID: 23551528]
19. Miyoshi J, Takai Y. Molecular perspective on tight-junction assembly and epithelial polarity. Adv Drug Deliv Rev. 2005; 57(6):815-55. [PMID: 15820555]
20. Vignaud T, Blanchoin L, Thery M. Directed cytoskeleton selforganization. Trends Cell Biol. 2012;22(12):671-82. doi: 10.1016/j.tcb.2012.08.012. [PMID: 23026031]
21. Berrier AL, Yamada KM. Cell-matrix adhesion. J Cell Physiol. 2007;213(3):565-73. [PMID: 17680633]
22. Ingber DE., Tensegrity I. Cell structure and hierarchical systems biology. J Cell Sci. 2003;116(Pt 7):1157-73. [PMID: 12615960]
23. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673-87. [PMID: 12297042]
24. Calderwood DA, Shattil SJ, Ginsberg MH. Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling. J Biol Chem. 2000;275(30):22607-10. [PMID: 10801899]
25. Wehrle-Haller B. Assembly and disassembly of cell matrix adhesions. Curr Opin Cell Biol. 2012;24(5):569-81. doi: 10.1016/j.ceb.2012.06.010. [PMID:22819514]
26. Wehrle-Haller B. Structure and function of focal adhesions. Curr Opin Cell Biol. 2012;24(1):116-24. doi: 10.1016/j.ceb.2011.11.001. [PMID: 22138388]
27. Horwitz A, Duggan K, Buck C, Beckerle MC, Burridge K. Interaction of plasma membrane fibronectin receptor with talina transmembrane linkage. Nature. 1986; 320(6062):531-3. [PMID: 2938015]
28. Burridge K, Turner CE, Romer LH. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol. 1992;119(4):893-903. [PMID: 1385444]
29. Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, Ballestrem C. Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol. 2007;179(5):1043-57. [PMID: 18056416]
30. Nagano M, Hoshino D, Koshikawa N, Akizawa T, Seiki M. Turnover of focal adhesions and cancer cell migration. Int J Cell Biol. 2012;2012:310616. doi: 10.1155/2012/310616. [PMID: 22319531]
31. Roca-Cusachs P, Del Rio A, Puklin-Faucher E, Gauthier NC, Biais N, Sheetz MP. Integrin-dependent force transmission to the extracellular matrix by α-actinin triggers adhesion maturation. Proc Natl Acad Sci U S A. 2013;110(15):E1361-70. doi: 10.1073/pnas.1220723110. [PMID: 23515331]
32. Spiering D, Hodgson L. Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adh Migr. 2011;5(2):170-80. [PMID: 21178402]
33. Huveneers S, Danen EH. Adhesion signaling - crosstalk between integrins, Src and Rho. J Cell Sci. 2009;122(Pt 8):1059- 69. doi: 10.1242/jcs.039446. [PMID: 19339545]
34. Fey EG, Wan KM, Penman S. Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: three-dimensional organization and protein composition. J Cell Biol. 1984;98(6):1973-84. [PMID:6202700]
35. Douglas T, Heinemann S, Bierbaum S, Scharnweber D, Worch H. Fibrillogenesis of collagen types I, II, and III with small leucine-rich proteoglycans decorin and biglycan. Biomacromolecules. 2006;7(8):2388-93. [PMID: 16903686]
36. Raspanti M, Viola M, Forlino A, Tenni R, Gruppi C, Tira ME. Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. J Struct Biol. 2008;164(1):134-9. doi: 10.1016/j.jsb.2008.07.001. [PMID: 18664384]
37. Theocharis AD, Skandalis SS, Tzanakakis GN, Karamanos NK. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J. 2010; 277(19):3904-23. doi: 10.1111/j.1742- 4658.2010.07800.x. [PMID: 20840587]
38. Couchman JR, Pataki CA. An introduction to proteoglycans and their localization. J Histochem Cytochem. 2012;60(12):885- 97. doi: 10.1369/0022155412464638. [PMID: 23019015]
39. Nelson CM, Bissell MJ. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2006;22:287- 309. [PMID: 16824016]
40. Ingber DE. Cellular mechanotransduction: putting all the pieces together again. FASEB J. 2006;20(7):811-27. [PMID: 16675838]
41. Liedl T, Hogberg B, Tytell J, Ingber DE, Shih WM. Selfassembly of three-dimensional prestressed tensegrity structures from DNA. Nat Nanotechnol. 2010 Jul;5(7):520-4. doi: 10.1038/nnano.2010.107. [PMID: 20562873]
42. Ingber DE. Tensegrity II. How structural networks influence cellular information processing networks. J Cell Sci. 2003;116(Pt 7):1397-408. [PMID: 12640025]
43. Fuller B. Tensegrity. Portfolio Artnews Annual. 1961; 4: 112- 127.]
44. Snelson K. Snelson on the tensegrity invention. Int J Space Struct 1996; 11: 43-48.
45. Ingber DE. Tensegrity-based mechanosensing from macro to micro. Prog Biophys Mol Biol. 2008;97(2-3):163-79. [PMID: 18406455]
46. Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of their substrate. Science. 2005;310(5751):1139- 43. [PMID: 16293750]
47. Buxboim A, Ivanovska IL, Discher DE. Matrix elasticity, cytoskeletal forces and physics of the nucleus: how deeply do cells 'feel' outside and in? J Cell Sci. 2010;123(Pt 3):297-308. doi: 10.1242/jcs.041186. [PMID: 20130138]
48. Mammoto A, Mammoto T, Ingber DE. Mechanosensitive mechanisms in transcriptional regulation. J Cell Sci. 2012;125 (Pt 13):3061-73. doi: 10.1242/jcs.093005. [PMID: 22797927]
49. Ingber DE. Mechanobiology and diseases of mechanotransduction. Ann Med. 2003;35(8):564-77. [PMID: 14708967]
50. Ingber D. Integrins as mechanochemical transducers. Curr Opin Cell Biol. 1991;3(5):841-8. [PMID: 1931084]
51. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 2010;24(3):349-58.
52. Yue J, Zhang K, Chen J. Role of integrins in regulating proteases to mediate extracellular matrix remodeling. Cancer Microenviron. 2012;5(3):275-83. doi: 10.1007/s12307-012- 0101-3.
53. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005; 8(3):241-54.
54. Buchholz M, Kestler HA, Holzmann K, Ellenrieder V, Schneiderhan W, Siech M, et al. Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype. J Mol Med (Berl). 2005;83(10):795-805. [PMID: 15976918]
55. Erkan M, Weis N, Pan Z, Schwager C, Samkharadze T, Jiang X et al. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer 2010;9:88 doi: 10.1186/1476-4598-9-88. [PMID: 20416094]
56. Zhang DY, Friedman SL. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology. 2012;56(2):769-75 doi: 10.1002/hep.25670. [PMID: 22378017]
57. Patsenker E, Stickel F. Role of integrins in fibrosing liver diseases. Am J Physiol Gastrointest Liver Physiol. 2011;301(3):G425-34. [PMID: 21659620]
58. Luo G, Long J, Zhang B, Liu C, Xu J, Ni Q et al. Stroma and pancreatic ductal adenocarcinoma: An interaction loop. Biochim Biophys Acta 2012;1826(1):170-8. [PMID: 22521638]
59. Riener MO, Fritzsche FR, Soll C, Pestalozzi BC, Probst-Hensch N, Clavien PA et al. Expression of the extracellular matrix protein periostin in liver tumors and bile duct carcinomas. Histopathology. 2010;56(5):600-6. doi: 10.1111/j.1365- 2559.2010.03527.x. [PMID: 20459570]
60. Baril P, Gangeswaran R, Mahon PC, Caulee K, Kocher HM, Harada T et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene. 2007;26(14):2082-94. [PMID: 17043657]
61. Lv Y, Wang W, Jia WD, Sun QK, Li JS, Ma JL et al. High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma. Med Oncol. 2013;30(1):385. doi: 10.1007/s12032-012-0385-7. [PMID: 23275141]
62. Tilman G, Mattiussi M, Brasseur F, van Baren N, Decottignies A. Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol Cancer. 2007;6:80. [PMID: 18086302]
63. Erkan M, Kleeff J, Gorbachevski A, Reiser C, Mitkus T, Esposito I, et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology. 2007;132(4):1447-64. [PMID: 17408641]
64. Imamura T, Iguchi H, Manabe T, Ohshio G, Yoshimura T, Wang ZH et al. Quantitative analysis of collagen and collagen subtypes I, III, and V in human pancreatic cancer, tumorassociated chronic pancreatitis, and alcoholic chronic pancreatitis. Pancreas. 1995;11(4):357-64. [PMID: 8532652]
65. Armstrong T, Packham G, Murphy LB, Bateman AC, Conti JA, Fine DR et al. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2004;10(21):7427-37. [PMID: 15534120]
66. Koenig A, Mueller C, Hasel C, Adler G, Menke A. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res. 2006;66(9):4662-71. [PMID: 16651417]
67. Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006;118(1):98-104. [PMID: 16815144]
68. Norris RA, Damon B, Mironov V, Kasyanov V, Ramamurthi A, Moreno-Rodriguez R et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem. 2007;101(3):695-711. [PMID: 17226767]
69. Ward BM. The taking of the cytoskeleton one two three: how viruses utilize the cytoskeleton during egress. Virology. 2011;411(2):244-50. doi: 10.1016/j.virol.2010.12.024. [PMID: 21241997]
70. Sun Q, Wang Y, Zhang Y, Liu F, Cheng X, Hou N et al. Expression profiling reveals dysregulation of cellular cytoskeletal genes in HBx-induced hepatocarcinogenesis. Cancer Biol Ther. 2007;6(5):668-74. [PMID: 17873514]
71. Cross JC, Wen P, Rutter WJ. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogenactivated cellular serine/threonine kinases. Proc Natl Acad Sci 1993; 90: 8078-82. [PMID: 8367466]
72. Benn J, Schneider R. Hepatitis B virus HBx protein activates Ras-GPT complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci 1994; 91: 10350-54. [PMID 7937954]
73. Klein NP, Schneider RJ Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Molec and Cell Biol 1997; 17: 6427-36. [PMID 9343405]
74. Bouchard MJ, Wang L, Schneider RJ. Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol. 2006;80(9):4406-14. [PMID: 16611900]
75. Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 2009;28(1-2):35-49. doi: 10.1007/s10555-008-9165-4. [PMID: 19169797]
76. Izaguirre G, Aguirre L, Hu YP, Lee HY, Schlaepfer DD, Aneskievich BJ et al. The cytoskeletal/non-muscle isoform of alpha-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase. J Biol Chem. 2001;276(31):28676-85. [PMID: 11369769]
77. Lara-Pezzi E, Serrador JM, Montoya MC, Zamora D, Yanez-Mo M, Carretero Mm, et al. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis. Hepatology;33(5):1270-81. [PMID: 11343256]
78. Steed E, Balda MS, Matter K. Dynamics and functions of tight junctions. Trends Cell Biol. 2010;20(3):142-9. doi: 10.1016/j.tcb.2009.12.002. [PMID: 20061152]
79. Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR et al. Ecadherin/ β-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011;2011:567305. doi: 10.1155/2011/567305. [PMID: 22007144]
80. Desai R, Sarpal R, Ishiyama N, Pellikka M, Ikura M, Tepass U. Monomeric α-catenin links cadherin to the actin cytoskeleton. Nat Cell Biol. 2013;15(3):261-73. doi: 10.1038/ncb2685. [PMID: 23417122]
81. Lara-Pezzi E, Roche S, Andrisani OM, Sanchez-Madrid F, Lopez-Cabrera M. The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner. Oncogene. 2001; 20(26):3323-31. [PMID: 10074921]
82. Chen L, Hu L, Li L, Liu Y, Tu QQ, Chang YX et al. Dysregulation of β-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas. Front Med China. 2010;4(4):399-411. doi: 10.1007/s11684-010-0170-y. [PMID: 21107751]
83. Menke A, Philippi C, Vogelmann R, Seidel B, Lutz MP, Adler G et al. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res. 2001;61(8):3508-17. [PMID: 11309315]
84. Lara-Pezzi E, Majano PL, Yanez-Mo M, Gomez-Gonzalo M, Carretero M, Moreno-Otero R et al. Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J Hepatol. 2001; 34(3):409-15. [PMID: 11322202]
85. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol. 1994;126(2):391-401. [PMID: 7518464]
86. Bost AG, Venable D, Liu L, Heinz BA. Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system. J Virol. 2003;77(7):4401-8. [PMID: 12634397]
87. Lai CK, Jeng KS, Machida K, Lai MM. Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A. J Virol. 2008; 82(17):8838-48. doi: 10.1128/JVI.00398-08. [PMID: 18562541]
88. Alisi A, Arciello M, Petrini S, Conti B, Missale G, Balsano C. Focal adhesion kinase (FAK) mediates the induction of prooncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)- infected cells. PLoS One. 2012;7(8):e44147. doi: 10.1371/journal.pone.0044147. [PMID: 22937161]
89. Lan S, Wang H, Jiang H, Mao H, Liu X, Zhang X et al. Direct interaction between alpha-actinin and hepatitis C virus NS5B. FEBS Lett. 2003;554(3):289-94. [PMID: 14623081]
90. Nakashima K, Takeuchi K, Chihara K, Horiguchi T, Sun X, Deng L et al. HCV NS5A protein containing potential ligands for both Src homology 2 and 3 domains enhances autophosphorylation of Src family kinase Fyn in B cells. PLoS One. 2012;7(10):e46634. doi: 10.1371/journal.pone.0046634. [PMID: 23077515]
91. Benedicto I, Molina-Jimenez F, Barreiro O, Maldonado- Rodriguez A, Prieto J, Moreno-Otero R et al. Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum. Hepatology. 2008;48(4):1044-53. doi: 10.1002/hep.22465. [PMID: 18802961]
92. Matter K, Balda MS. Epithelial tight junctions, gene expression and nucleo-junctional interplay. J Cell Sci. 2007;120(Pt 9):1505- 11. [PMID: 17452622]
93. Aijaz S, Balda MS, Matter K. Tight junctions: molecular architecture and function. Int Rev Cytol. 2006;248:261-98. [PMID: 16487793]
94. Tan TL, Feng Z, Lu YW, Chan V, Chen WN. Adhesion contact kinetics of HepG2 cells during Hepatitis B virus replication: Involvement of SH3-binding motif in HBX. Biochim Biophys Acta. 2006;1762(8):755-66. [PMID: 19339545]
95. Huveneers S, Danen EH. Adhesion signaling - crosstalk between integrins, Src and Rho. J Cell Sci. 2009;122(Pt 8):1059- 69. doi: 10.1242/jcs.039446. [PMID: 19339545]
96. Zhao G, Cui J, Qin Q, Zhang J, Liu L, Deng S et al. Mechanical stiffness of liver tissues in relation to integrin β1 expression may influence the development of hepatic cirrhosis and hepatocellular carcinoma. Surg Oncol. 2010;102(5):482-9. doi: 10.1002/jso.21613. [PMID: 20872952]
97. Popov Y, Patsenker E, Stickel F, Zaks J, Bhaskar KR, Niedobitek G et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol. 2008;48(3):453-64. doi: 10.1016/j.jhep.2007.11.021. [PMID: 18221819]
98. Nejjari M, Couvelard A, Mosnier JF, Moreau A, Feldmann G, Degott C et al. Integrin up-regulation in chronic liver disease: relationship with inflammation and fibrosis in chronic hepatitis C. J Pathol. 2001;195(4):473-81. [PMID: 11745680]
99. Martin-Vilchez S, Sanz-Cameno P, Rodriguez-Munoz Y, Majano PL, Molina-Jimenez F, Lopez-Cabrera M et al. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 2008;47(6):1872-83. [PMID: 18449922]
100. Watanabe N, Aizaki H, Matsuura T, Kojima S, Wakita T, Suzuki T. Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules. Biochem Biophys Res Commun. 2011;407(1):135-40. doi: 10.1016/j.bbrc.2011.02.125. [PMID: 21371436]
101. Liu X, Zhu ST, You H, Cong M, Liu TH, Wang BE et al. Hepatitis B virus infects hepatic stellate cells and affects their proliferation and expression of collagen type I. Chin Med J (Engl). 2009;122(12):1455-61. [PMID: 19567171]
102. Schulze-Krebs A, Preimel D, Popov Y, Bartenschlager R, Lohmann V, Pinzani M et al. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology 2005;129(1):246-58. [PMID: 16012951]
103. Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology. 2007;46(6):1759-68. [PMID: 18046710]
104. Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology. 2013;57(3):985-94. doi: 10.1002/hep.26125. [PMID: 23161433]
105. Barth H, Schnober EK, Zhang F, Linhardt RJ, Depla E Boson B et al. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol 2006; 80: 10579- 10590. [PMID: 16928753]
106. Fung J, Lai CL, Seto WK, Wong DK, Yuen MF. Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B. J Viral Hepat. 2011;18(10):738-44.doi: 10.1111/j.1365-2893.2010.01355.x. [PMID: 20659306]
107. Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology. 2011;140(7):1970-9, 1979.e1-3. doi: 10.1053/j.gastro.2011.02.058. [PMID: 21376047]